Legal & General Group’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $45.4K | Sell |
11,785
-75,494
| -86% | -$276K | ﹤0.01% | 2798 |
|
|
2026
Q1 | $351K | Sell |
87,279
-26,184
| -23% | -$132K | ﹤0.01% | 2446 |
|
|
2025
Q4 | $775K | Sell |
113,463
-17,256
| -13% | -$121K | ﹤0.01% | 2287 |
|
|
2025
Q3 | $913K | Sell |
130,719
-717
| -0.5% | -$4.98K | ﹤0.01% | 2268 |
|
|
2025
Q2 | $801K | Buy |
131,436
+13,867
| +12% | +$92.2K | ﹤0.01% | 2299 |
|
|
2025
Q1 | $894K | Sell |
117,569
-7,476
| -6% | -$62.5K | ﹤0.01% | 2224 |
|
|
2024
Q4 | $1.2M | Buy |
125,045
+7,605
| +6% | +$59.2K | ﹤0.01% | 2172 |
|
|
2024
Q3 | $696K | Buy |
117,440
+1,855
| +2% | +$12.3K | ﹤0.01% | 2354 |
|
|
2024
Q2 | $801K | Buy |
115,585
+2,033
| +2% | +$14.3K | ﹤0.01% | 2266 |
|
|
2024
Q1 | $876K | Hold |
113,552
| – | – | ﹤0.01% | 2238 |
|
|
2023
Q4 | $996K | Buy |
113,552
+1,495
| +1% | +$10.9K | ﹤0.01% | 2213 |
|
|
2023
Q3 | $818K | Buy |
112,057
+44,491
| +66% | +$331K | ﹤0.01% | 2261 |
|
|
2023
Q2 | $446K | Buy |
67,566
+36,112
| +115% | +$184K | ﹤0.01% | 2503 |
|
|
2023
Q1 | $107K | Buy |
31,454
+643
| +2% | +$2.49K | ﹤0.01% | 2768 |
|
|
2022
Q4 | $85.7K | Buy |
30,811
+2,725
| +10% | +$8.15K | ﹤0.01% | 2850 |
|
|
2022
Q3 | $81K | Buy |
28,086
+748
| +3% | +$2.66K | ﹤0.01% | 2876 |
|
|
2022
Q2 | $95K | Sell |
27,338
-941
| -3% | -$3.69K | ﹤0.01% | 2869 |
|
|
2022
Q1 | $133K | Hold |
28,279
| – | – | ﹤0.01% | 2796 |
|
|
2021
Q4 | $171K | Buy |
28,279
+51
| +0.2% | +$354 | ﹤0.01% | 2771 |
|
|
2021
Q3 | $171K | Buy |
28,228
+14,293
| +103% | +$161K | ﹤0.01% | 2732 |
|
|
2021
Q2 | $174K | Buy |
+13,935
| New | +$151K | ﹤0.01% | 2573 |
|
|
2018
Q4 | – | Sell |
-235,518
| Closed | -$1.45M | – | 3390 |
|
|
2018
Q3 | $1.45M | Buy |
235,518
+14,224
| +6% | +$64.3K | ﹤0.01% | 1835 |
|
|
2018
Q2 | $1.41M | Buy |
221,294
+10,713
| +5% | +$76.3K | ﹤0.01% | 1800 |
|
|
2018
Q1 | $1.47M | Sell |
210,581
-4,209
| -2% | -$49K | ﹤0.01% | 1748 |
|
|
2017
Q4 | $2.71M | Sell |
214,790
-2,770
| -1% | -$33.8K | ﹤0.01% | 1455 |
|
|
2017
Q3 | $2.58M | Buy |
217,560
+33,784
| +18% | +$501K | ﹤0.01% | 1441 |
|
|
2017
Q2 | $2.75M | Buy |
183,776
+18,006
| +11% | +$240K | ﹤0.01% | 1346 |
|
|
2017
Q1 | $1.58M | Sell |
165,770
-525
| -0.3% | -$4.43K | ﹤0.01% | 1611 |
|
|
2016
Q4 | $1.47M | Buy |
166,295
+80,645
| +94% | +$725K | ﹤0.01% | 1582 |
|
|
2016
Q3 | $732K | Buy |
85,650
+69,467
| +429% | +$550K | ﹤0.01% | 1527 |
|
|
2016
Q2 | $126K | Hold |
16,183
| – | – | ﹤0.01% | 1973 |
|
|
2016
Q1 | $142K | Buy |
16,183
+1,343
| +9% | +$11.2K | ﹤0.01% | 1858 |
|
|
2015
Q4 | $139K | Hold |
14,840
| – | – | ﹤0.01% | 1901 |
|
|
2015
Q3 | $141K | Hold |
14,840
| – | – | ﹤0.01% | 1863 |
|
|
2015
Q2 | $171K | Hold |
14,840
| – | – | ﹤0.01% | 1811 |
|
|
2015
Q1 | $155K | Hold |
14,840
| – | – | ﹤0.01% | 1790 |
|
|
2014
Q4 | $173K | Hold |
14,840
| – | – | ﹤0.01% | 1646 |
|
|
2014
Q3 | $108K | Buy |
+14,840
| New | +$103K | ﹤0.01% | 1837 |
|
Other funds holding MDXG
EWM
TI
NCM
PCMI
Legal & General Group's MDXG Position: Q2 2026 in Review
Legal & General Group reduced its MiMedx Group (MDXG) stake by 86% in Q2 2026, selling an estimated $276K and leaving 11,785 shares worth $45.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2798.
Legal & General Group first reported a position in MDXG in Q3 2014 and has held it in 38 quarters since. The position peaked at $2.75M in Q2 2017. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.
- Legal & General Group held 11,785 shares of MiMedx Group worth $45.4K as of Q2 2026.
- Legal & General Group sold 75,494 MiMedx Group shares in Q2 2026, an estimated $276K.
- MiMedx Group made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2798 holding.
- Legal & General Group first reported a position in MiMedx Group in Q3 2014 and has held it in 38 quarters since.
- Legal & General Group's MiMedx Group position peaked at $2.75M in Q2 2017.
- 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.
Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.